Revolution Medicines (RVMD) Shares Outstanding (2019 - 2026)

Revolution Medicines' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $200.2 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 7.47% year-over-year to $200.2 million in Q1 2026; TTM through Mar 2026 was $200.2 million, a 7.47% increase from a year earlier, with the FY2025 full-year figure at $197.0 million, up 5.97% from the prior year.
• Shares Outstanding (Entity) advanced to $200.2 million in Q1 2026 per RVMD's latest filing, from $197.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $200.2 million in Q1 2026 and bottomed at $74.2 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $170.5 million (2024), against an average of $142.7 million.
• Across the five-year window, Shares Outstanding (Entity) advanced 1.08% in 2022 and soared 64.29% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $90.4 million in 2022, then grew by 25.15% to $113.1 million in 2023, then soared by 64.29% to $185.9 million in 2024, then advanced by 5.97% to $197.0 million in 2025, then advanced by 1.61% to $200.2 million in 2026.
• Per Business Quant, the three latest RVMD Shares Outstanding (Entity) figures stand at $200.2 million (Q1 2026), $197.0 million (Q4 2025), and $189.7 million (Q3 2025).